Savara Inc. (SVRA)

USD 2.87

(-1.21%)

Total Liabilities Summary of Savara Inc.

  • Savara Inc.'s latest annual total liabilities in 2023 was 37.19 Million USD , up 16.23% from previous year.
  • Savara Inc.'s latest quarterly total liabilities in 2024 Q2 was 37.93 Million USD , up 4.13% from previous quarter.
  • Savara Inc. reported annual total liabilities of 31.99 Million USD in 2022, down -0.31% from previous year.
  • Savara Inc. reported annual total liabilities of 32.1 Million USD in 2021, down -3.78% from previous year.
  • Savara Inc. reported quarterly total liabilities of 36.43 Million USD for 2024 Q1, down -2.04% from previous quarter.
  • Savara Inc. reported quarterly total liabilities of 37.19 Million USD for 2023 FY, up 16.23% from previous quarter.

Annual Total Liabilities Chart of Savara Inc. (2023 - 2000)

Historical Annual Total Liabilities of Savara Inc. (2023 - 2000)

Year Total Liabilities Total Liabilities Growth
2023 37.19 Million USD 16.23%
2022 31.99 Million USD -0.31%
2021 32.1 Million USD -3.78%
2020 33.36 Million USD -3.31%
2019 34.5 Million USD -77.34%
2018 152.28 Million USD 277.71%
2017 40.31 Million USD -37.79%
2016 64.8 Million USD 113.69%
2015 30.32 Million USD 156.11%
2014 11.84 Million USD 59.12%
2013 7.44 Million USD 43.69%
2012 5.17 Million USD 2.02%
2011 5.07 Million USD 181.82%
2010 1.8 Million USD -23.46%
2009 2.35 Million USD -50.07%
2008 4.71 Million USD 34.41%
2007 3.5 Million USD -89.32%
2006 32.84 Million USD 4.42%
2005 31.45 Million USD 2481.29%
2004 1.21 Million USD 647.29%
2003 163.04 Thousand USD -83.41%
2002 983.07 Thousand USD 7.26%
2001 916.49 Thousand USD 241.25%
2000 268.57 Thousand USD 0.0%

Peer Total Liabilities Comparison of Savara Inc.

Name Total Liabilities Total Liabilities Difference
AbCellera Biologics Inc. 335.77 Million USD 88.924%
Alkermes plc 933.53 Million USD 96.016%
Agenus Inc. 462.29 Million USD 91.955%
Alnylam Pharmaceuticals, Inc. 4.05 Billion USD 99.082%
Aptorum Group Limited 5.25 Million USD -607.511%
Ardelyx, Inc. 130.76 Million USD 71.558%
Arrowhead Pharmaceuticals, Inc. 478.39 Million USD 92.226%
Bicycle Therapeutics plc 224.41 Million USD 83.427%
BioXcel Therapeutics, Inc. 130.21 Million USD 71.437%
ChromaDex Corporation 26.5 Million USD -40.305%
Chimerix, Inc. 19.74 Million USD -88.362%
Corbus Pharmaceuticals Holdings, Inc. 35.17 Million USD -5.728%
Caribou Biosciences, Inc. 72.56 Million USD 48.748%
CRISPR Therapeutics AG 346.76 Million USD 89.275%
Precision BioSciences, Inc. 140.92 Million USD 73.608%
Dyadic International, Inc. 2.34 Million USD -1488.96%
Eton Pharmaceuticals, Inc. 16.26 Million USD -128.691%
Fortress Biotech, Inc. 165.93 Million USD 77.587%
Lantern Pharma Inc. 2.73 Million USD -1257.53%
HOOKIPA Pharma Inc. 71.48 Million USD 47.969%
Inhibikase Therapeutics, Inc. 3.52 Million USD -953.978%
Incyte Corporation 1.59 Billion USD 97.664%
IO Biotech, Inc. 17.55 Million USD -111.848%
Jaguar Health, Inc. 45.86 Million USD 18.912%
Novavax, Inc. 2.57 Billion USD 98.554%
Janux Therapeutics, Inc. 36.05 Million USD -3.145%
Opthea Limited 264.6 Million USD 85.944%
Ligand Pharmaceuticals Incorporated 130.7 Million USD 71.546%
ContextLogic Inc. 206 Million USD 81.946%
MiMedx Group, Inc. 96.33 Million USD 61.391%
Pyxis Oncology, Inc. 48.02 Million USD 22.552%
TransCode Therapeutics, Inc. 3.52 Million USD -953.93%
NextCure, Inc. 14.99 Million USD -147.996%
Ocuphire Pharma, Inc. 4.04 Million USD -820.139%
Oncternal Therapeutics, Inc. 6.67 Million USD -457.017%
Outlook Therapeutics, Inc. 46.73 Million USD 20.426%
Vaxcyte, Inc. 167.44 Million USD 77.789%
PDS Biotechnology Corporation 33.25 Million USD -11.825%
Madrigal Pharmaceuticals, Inc. 235.21 Million USD 84.188%
Pharming Group N.V. 244.07 Million USD 84.762%
Pieris Pharmaceuticals, Inc. 11.92 Million USD -211.961%
Avidity Biosciences, Inc. 127.79 Million USD 70.896%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -462.894%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -462.894%
Sangamo Therapeutics, Inc. 82.43 Million USD 54.882%
Sol-Gel Technologies Ltd. 6.64 Million USD -459.868%
Acelyrin, Inc. 86.35 Million USD 56.93%
Salarius Pharmaceuticals, Inc. 1.29 Million USD -2762.594%
SELLAS Life Sciences Group, Inc. 14.37 Million USD -158.655%
Summit Therapeutics Inc. 125.25 Million USD 70.307%
Sensei Biotherapeutics, Inc. 9.47 Million USD -292.362%
Senti Biosciences, Inc. 52.57 Million USD 29.254%
Stoke Therapeutics, Inc. 68.77 Million USD 45.924%
Syros Pharmaceuticals, Inc. 151.51 Million USD 75.453%
Alaunos Therapeutics, Inc. 1.95 Million USD -1801.431%
Telomir Pharmaceuticals, Inc. Common Stock 1.33 Million USD -2684.741%
Entrada Therapeutics, Inc. 226.83 Million USD 83.604%
VistaGen Therapeutics, Inc. 9.36 Million USD -297.053%
Wave Life Sciences Ltd. 227.44 Million USD 83.648%
Sorrento Therapeutics, Inc. 494.5 Million USD 92.479%
TRACON Pharmaceuticals, Inc. 10.91 Million USD -240.773%
Barinthus Biotherapeutics plc 27.51 Million USD -35.19%
Psyence Biomedical Ltd. 12.1 Million USD -207.253%
Phathom Pharmaceuticals, Inc. 486.6 Million USD 92.357%
Immix Biopharma, Inc. 3.72 Million USD -899.306%
Keros Therapeutics, Inc. 37.81 Million USD 1.64%
MEI Pharma, Inc. 8.35 Million USD -345.147%
Windtree Therapeutics, Inc. 29.01 Million USD -28.182%
Xeris Biopharma Holdings, Inc. 347.58 Million USD 89.3%
Rigel Pharmaceuticals, Inc. 145.86 Million USD 74.503%
Fortress Biotech, Inc. 165.93 Million USD 77.587%
Precigen, Inc. 41.64 Million USD 10.691%
Clearside Biomedical, Inc. 49.93 Million USD 25.512%
AlloVir, Inc. 45.01 Million USD 17.379%
C4 Therapeutics, Inc. 130.33 Million USD 71.465%
Fate Therapeutics, Inc. 137.8 Million USD 73.01%
ImmuCell Corporation 18.81 Million USD -97.672%
IDEAYA Biosciences, Inc. 28.22 Million USD -31.765%
Onconetix, Inc. 23.18 Million USD -60.443%
PureTech Health plc 125.58 Million USD 70.385%
VYNE Therapeutics Inc. 8.95 Million USD -315.553%
Elevation Oncology, Inc. 34.28 Million USD -8.488%
Kintara Therapeutics, Inc. 2.44 Million USD -1421.145%
Seer, Inc. 39.36 Million USD 5.52%
Verrica Pharmaceuticals Inc. 61.83 Million USD 39.852%
Innoviva, Inc. 568.55 Million USD 93.458%
Aadi Bioscience, Inc. 27.22 Million USD -36.595%
ESSA Pharma Inc. 3.49 Million USD -964.127%
GlycoMimetics, Inc. 6.9 Million USD -438.853%
GT Biopharma, Inc. 6.63 Million USD -460.712%
Inhibrx Biosciences, Inc. 264.39 Million USD 85.933%
Akebia Therapeutics, Inc. 272.28 Million USD 86.341%
Catalyst Pharmaceuticals, Inc. 84.02 Million USD 55.738%
Longboard Pharmaceuticals, Inc. 9.77 Million USD -280.52%
Orchestra BioMed Holdings, Inc. 27.16 Million USD -36.891%
Alzamend Neuro, Inc. 3.22 Million USD -1052.964%
Rocket Pharmaceuticals, Inc. 73.76 Million USD 49.582%
Aptose Biosciences Inc. 15.8 Million USD -135.263%
ZyVersa Therapeutics, Inc. 11.03 Million USD -236.894%
Soligenix, Inc. 7.27 Million USD -411.237%
Century Therapeutics, Inc. 175.94 Million USD 78.861%
Kura Oncology, Inc. 51.66 Million USD 28.009%
TScan Therapeutics, Inc. 121.28 Million USD 69.334%
Intensity Therapeutics, Inc. 4.13 Million USD -799.879%
Ocean Biomedical, Inc. 6.61 Million USD -462.335%
CytomX Therapeutics, Inc. 252.59 Million USD 85.276%
Autolus Therapeutics plc 263.9 Million USD 85.907%
Mineralys Therapeutics, Inc. 10.48 Million USD -254.818%
EyePoint Pharmaceuticals, Inc. 88.86 Million USD 58.146%
Eterna Therapeutics Inc. 46.89 Million USD 20.698%
Adaptive Biotechnologies Corporation 352.85 Million USD 89.46%
GRI Bio, Inc. 2.69 Million USD -1279.014%
Xenetic Biosciences, Inc. 809.58 Thousand USD -4493.959%
Tenaya Therapeutics, Inc. 31.09 Million USD -19.623%
IGM Biosciences, Inc. 220.17 Million USD 83.108%
INmune Bio, Inc. 18.86 Million USD -97.18%
Heron Therapeutics, Inc. 256.47 Million USD 85.499%
SAB Biotherapeutics, Inc. 26.64 Million USD -39.6%
Pasithea Therapeutics Corp. 2.71 Million USD -1268.155%
Entero Therapeutics, Inc. 3.28 Million USD -1033.81%
Milestone Pharmaceuticals Inc. 58.45 Million USD 36.375%
X4 Pharmaceuticals, Inc. 96.15 Million USD 61.322%
Atara Biotherapeutics, Inc. 264.73 Million USD 85.951%
Coherus BioSciences, Inc. 823.02 Million USD 95.481%
Verastem, Inc. 71.18 Million USD 47.753%
Abeona Therapeutics Inc. 49.17 Million USD 24.37%
Pliant Therapeutics, Inc. 38.57 Million USD 3.593%
Tonix Pharmaceuticals Holding Corp. 48.93 Million USD 23.992%
Histogen Inc. 5.69 Million USD -552.835%
Aprea Therapeutics, Inc. 4.38 Million USD -748.047%
Surrozen, Inc. 8.14 Million USD -356.624%
Organovo Holdings, Inc. 2.74 Million USD -1253.421%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -11749.945%
Ovid Therapeutics Inc. 56.22 Million USD 33.857%
Panbela Therapeutics, Inc. 16.51 Million USD -125.242%
CASI Pharmaceuticals, Inc. 51.1 Million USD 27.221%
Cadrenal Therapeutics, Inc. Common Stock 826.87 Thousand USD -4397.899%
Centessa Pharmaceuticals plc 126.72 Million USD 70.651%
Hepion Pharmaceuticals, Inc. 10.81 Million USD -243.938%
Arcturus Therapeutics Holdings Inc. 150.88 Million USD 75.351%
BioRestorative Therapies, Inc. 2.6 Million USD -1326.432%
Apollomics, Inc. 14.15 Million USD -162.785%
Amarin Corporation plc 279.58 Million USD 86.698%
Mesoblast Limited 188.79 Million USD 80.301%
Turnstone Biologics Corp. 14.14 Million USD -162.878%
Kymera Therapeutics, Inc. 180.78 Million USD 79.428%
Synaptogenix, Inc. 5.52 Million USD -572.614%
Tiziana Life Sciences Ltd 6.64 Million USD -459.446%
Aurinia Pharmaceuticals Inc. 170.1 Million USD 78.136%
BriaCell Therapeutics Corp. 8.55 Million USD -334.629%
Monopar Therapeutics Inc. 1.75 Million USD -2016.317%
Exelixis, Inc. 678.44 Million USD 94.518%
Better Therapeutics, Inc. 23.84 Million USD -55.994%
Nurix Therapeutics, Inc. 164.04 Million USD 77.328%
Apellis Pharmaceuticals, Inc. 594.2 Million USD 93.741%
NLS Pharmaceutics AG 10.68 Million USD -248.233%
Dermata Therapeutics, Inc. 1.62 Million USD -2190.689%
Aridis Pharmaceuticals, Inc. 38.92 Million USD 4.457%
Gritstone bio, Inc. 125.91 Million USD 70.464%
Jasper Therapeutics, Inc. 14.67 Million USD -153.421%
TNF Pharmaceuticals, Inc. 5.08 Million USD -630.885%
Avid Bioservices, Inc. 275.66 Million USD 86.508%
Insmed Incorporated 1.66 Billion USD 97.762%
Virpax Pharmaceuticals, Inc. 7.69 Million USD -383.388%
MediWound Ltd. 27.18 Million USD -36.801%
OmniAb, Inc. 87.4 Million USD 57.446%
Alector, Inc. 487.66 Million USD 92.374%
Seres Therapeutics, Inc. 403.45 Million USD 90.782%
Checkpoint Therapeutics, Inc. 18.42 Million USD -101.856%
Viracta Therapeutics, Inc. 38.37 Million USD 3.078%
Zai Lab Limited 240.17 Million USD 84.515%
Revance Therapeutics, Inc. 630.05 Million USD 94.097%
Aura Biosciences, Inc. 29.22 Million USD -27.252%
Lyell Immunopharma, Inc. 95.07 Million USD 60.882%
Immunic, Inc. 25.36 Million USD -46.61%
Tarsus Pharmaceuticals, Inc. 69.23 Million USD 46.282%
Veracyte, Inc. 93.71 Million USD 60.315%
InMed Pharmaceuticals Inc. 2.61 Million USD -1321.347%
FibroGen, Inc. 585.72 Million USD 93.65%
SeaStar Medical Holding Corporation 17.38 Million USD -113.956%
Adial Pharmaceuticals, Inc. 653.07 Thousand USD -5594.896%
Sonnet BioTherapeutics Holdings, Inc. 5.65 Million USD -557.63%
Jazz Pharmaceuticals plc 7.65 Billion USD 99.514%
Cyclacel Pharmaceuticals, Inc. 8.19 Million USD -353.672%
Amylyx Pharmaceuticals, Inc. 84.02 Million USD 55.735%
TG Therapeutics, Inc. 169.08 Million USD 78.004%
Galecto, Inc. 5.89 Million USD -530.801%
Calithera Biosciences, Inc. 8.28 Million USD -348.962%
Fortrea Holdings Inc. 2.61 Billion USD 98.58%
KalVista Pharmaceuticals, Inc. 28.82 Million USD -29.04%
Aptevo Therapeutics Inc. 12.62 Million USD -194.683%
XBiotech Inc. 8.39 Million USD -342.92%
Jasper Therapeutics, Inc. 14.67 Million USD -153.421%
Lyra Therapeutics, Inc. 53.18 Million USD 30.064%
Foghorn Therapeutics Inc. 363.1 Million USD 89.757%
Y-mAbs Therapeutics, Inc. 26.88 Million USD -38.343%
Theravance Biopharma, Inc. 169 Million USD 77.993%
Ultragenyx Pharmaceutical Inc. 1.21 Billion USD 96.94%
Metagenomi, Inc. Common Stock 500.42 Million USD 92.568%
Vaxxinity, Inc. 30.94 Million USD -20.191%
BioCryst Pharmaceuticals, Inc. 972.48 Million USD 96.176%
Gain Therapeutics, Inc. 6.03 Million USD -516.67%
Cartesian Therapeutics, Inc. 745.23 Million USD 95.009%
NexImmune, Inc. 5.08 Million USD -631.517%
Creative Medical Technology Holdings, Inc. 371.39 Thousand USD -9914.163%
Marker Therapeutics, Inc. 3.07 Million USD -1109.556%
Regeneron Pharmaceuticals, Inc. 7.1 Billion USD 99.477%
Chemomab Therapeutics Ltd. 5.15 Million USD -621.61%
Scopus BioPharma Inc. 7.45 Million USD -398.925%
RAPT Therapeutics, Inc. 26.29 Million USD -41.447%
Ainos, Inc. 7.39 Million USD -402.987%
Pluri Inc. 34.11 Million USD -9.029%
Prothena Corporation plc 135.01 Million USD 72.454%
Adaptimmune Therapeutics plc 243.1 Million USD 84.701%
Celularity Inc. 102.92 Million USD 63.866%
Rallybio Corporation 9.43 Million USD -294.15%
Cue Biopharma, Inc. 24.44 Million USD -52.146%
MeiraGTx Holdings plc 319.99 Million USD 88.377%
Omeros Corporation 403.25 Million USD 90.777%
Humacyte, Inc. 114.67 Million USD 67.568%
Immunocore Holdings plc 228.15 Million USD 83.699%
Cocrystal Pharma, Inc. 4.87 Million USD -662.913%
Cidara Therapeutics, Inc. 76.74 Million USD 51.535%
Blueprint Medicines Corporation 918.64 Million USD 95.951%
CalciMedica, Inc. 4.02 Million USD -823.337%
Cabaletta Bio, Inc. 17.45 Million USD -113.11%
Marinus Pharmaceuticals, Inc. 154.14 Million USD 75.872%
Scholar Rock Holding Corporation 85.81 Million USD 56.661%
Sana Biotechnology, Inc. 277.79 Million USD 86.612%
Pulmatrix, Inc. 15.96 Million USD -132.989%
Elicio Therapeutics, Inc. 15.77 Million USD -135.795%
Vigil Neuroscience, Inc. 24.6 Million USD -51.15%
Intellia Therapeutics, Inc. 250.8 Million USD 85.171%
Adlai Nortye Ltd. American Depositary Shares 50.78 Million USD 26.767%
Cytokinetics, Incorporated 1.21 Billion USD 96.928%
Eloxx Pharmaceuticals, Inc. 31.78 Million USD -17.019%
Nutriband Inc. 1.07 Million USD -3347.154%
Protara Therapeutics, Inc. 10.63 Million USD -249.779%
Vor Biopharma Inc. 59.1 Million USD 37.074%
Roivant Sciences Ltd. 773.95 Million USD 95.195%
Evogene Ltd. 17.99 Million USD -106.737%
ProKidney Corp. 29.21 Million USD -27.3%
Applied Therapeutics, Inc. 71.97 Million USD 48.329%
Hoth Therapeutics, Inc. 704.98 Thousand USD -5175.588%
BridgeBio Pharma, Inc. 1.88 Billion USD 98.031%
CorMedix Inc. 11.91 Million USD -212.078%
BioLineRx Ltd. 50.7 Million USD 26.646%
Tango Therapeutics, Inc. 149.45 Million USD 75.116%
Galectin Therapeutics Inc. 88.44 Million USD 57.947%
Atai Life Sciences N.V. 49.16 Million USD 24.348%
Renovaro Biosciences Inc. 31.15 Million USD -19.388%
Aerovate Therapeutics, Inc. 17.96 Million USD -107.059%
Zentalis Pharmaceuticals, Inc. 124.63 Million USD 70.16%
Sagimet Biosciences Inc. 5.65 Million USD -557.8%
MediciNova, Inc. 3.89 Million USD -855.711%
Praxis Precision Medicines, Inc. 18.27 Million USD -103.468%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -2372.476%
GeoVax Labs, Inc. 3.51 Million USD -956.627%
Axsome Therapeutics, Inc. 397.25 Million USD 90.638%
Biomea Fusion, Inc. 30.69 Million USD -21.186%
PTC Therapeutics, Inc. 2.72 Billion USD 98.634%
Mereo BioPharma Group plc 15.96 Million USD -133.003%
Cullinan Oncology, Inc. 31.2 Million USD -19.201%
Syndax Pharmaceuticals, Inc. 58.68 Million USD 36.623%
Absci Corporation 58.3 Million USD 36.21%
NRx Pharmaceuticals, Inc. 19.04 Million USD -95.254%
4D Molecular Therapeutics, Inc. 32.06 Million USD -16.0%
Dyne Therapeutics, Inc. 73.79 Million USD 49.598%
Kiniksa Pharmaceuticals, Ltd. 87.48 Million USD 57.487%
Ventyx Biosciences, Inc. 33.77 Million USD -10.133%
Allakos Inc. 74.79 Million USD 50.273%
Imunon, Inc. 8.53 Million USD -335.992%
Fulcrum Therapeutics, Inc. 22.5 Million USD -65.29%
Corcept Therapeutics Incorporated 114.81 Million USD 67.606%
BioAtla, Inc. 48.98 Million USD 24.076%
NLS Pharmaceutics AG 10.68 Million USD -248.233%
Bio-Path Holdings, Inc. 2.77 Million USD -1238.323%
Allogene Therapeutics, Inc. 130.6 Million USD 71.523%
Larimar Therapeutics, Inc. 14.21 Million USD -161.639%
XOMA Corporation 145.58 Million USD 74.453%
Kezar Life Sciences, Inc. 33.66 Million USD -10.477%
Cara Therapeutics, Inc. 68.75 Million USD 45.91%
aTyr Pharma, Inc. 31.59 Million USD -17.707%
Aligos Therapeutics, Inc. 61.82 Million USD 39.841%
Akero Therapeutics, Inc. 44.96 Million USD 17.287%
Viridian Therapeutics, Inc. 48.4 Million USD 23.16%
Eliem Therapeutics, Inc. 2.87 Million USD -1195.889%
EyeGate Pharmaceuticals, Inc. 8.15 Million USD -355.895%
Akari Therapeutics, Plc 4.58 Million USD -711.344%
Tevogen Bio Holdings Inc. 17.73 Million USD -109.732%
Halozyme Therapeutics, Inc. 1.64 Billion USD 97.745%
Lexaria Bioscience Corp. 403.9 Thousand USD -9108.037%
UroGen Pharma Ltd. 243.52 Million USD 84.728%
Sutro Biopharma, Inc. 321.08 Million USD 88.417%
ZIVO Bioscience, Inc. 2.76 Million USD -1246.776%
Orgenesis Inc. 35.53 Million USD -4.663%
Entera Bio Ltd. 1.37 Million USD -2597.027%
GH Research PLC 6.7 Million USD -455.022%
Lisata Therapeutics, Inc. 6.8 Million USD -446.941%
Reneo Pharmaceuticals, Inc. 18.82 Million USD -97.557%
Xencor, Inc. 283.55 Million USD 86.884%
60 Degrees Pharmaceuticals, Inc. 2.98 Million USD -1145.681%
Replimune Group, Inc. 113.21 Million USD 67.149%
Coeptis Therapeutics Holdings, Inc. 3.75 Million USD -889.906%
Vanda Pharmaceuticals Inc. 103.53 Million USD 64.076%
Lexaria Bioscience Corp. 403.9 Thousand USD -9108.037%
Portage Biotech Inc. 4.45 Million USD -735.775%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -2372.476%
Olema Pharmaceuticals, Inc. 23.05 Million USD -61.354%
OncoCyte Corporation 49.29 Million USD 24.557%
Qualigen Therapeutics, Inc. 4.13 Million USD -799.051%
Processa Pharmaceuticals, Inc. 797.48 Thousand USD -4563.667%
Purple Biotech Ltd. 10 Million USD -271.734%
CollPlant Biotechnologies Ltd. 5.78 Million USD -542.793%
scPharmaceuticals Inc. 57.26 Million USD 35.048%
ProMIS Neurosciences, Inc. 12.38 Million USD -200.226%
HilleVax, Inc. 78.9 Million USD 52.867%
NeuroSense Therapeutics Ltd. 5.05 Million USD -636.475%
Tharimmune, Inc. 1.81 Million USD -1949.094%
Genprex, Inc. 3.25 Million USD -1042.889%
Neumora Therapeutics, Inc. Common Stock 27.11 Million USD -37.144%
Atossa Therapeutics, Inc. 5.23 Million USD -610.313%
XTL Biopharmaceuticals Ltd. 206 Thousand USD -17954.369%
Virios Therapeutics, Inc. 358.54 Thousand USD -10272.949%
OKYO Pharma Limited 7.42 Million USD -401.183%
Curis, Inc. 57.61 Million USD 35.444%
Daré Bioscience, Inc. 26.32 Million USD -41.254%
Carmell Therapeutics Corporation 39.19 Million USD 5.122%
Titan Pharmaceuticals, Inc. 1.44 Million USD -2475.623%
Achieve Life Sciences, Inc. 20.81 Million USD -78.645%
BeiGene, Ltd. 2.23 Billion USD 98.335%
Kiromic BioPharma, Inc. 21.28 Million USD -74.694%
Revolution Medicines, Inc. Warrant 262.39 Million USD 85.826%
Protagonist Therapeutics, Inc. 21.27 Million USD -74.824%
Erasca, Inc. 78.61 Million USD 52.689%
bluebird bio, Inc. 424.62 Million USD 91.241%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -5575.984%
BioMarin Pharmaceutical Inc. 1.89 Billion USD 98.032%
DBV Technologies S.A. 42.8 Million USD 13.103%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -5575.984%
Moderna, Inc. 4.57 Billion USD 99.187%
Vincerx Pharma, Inc. 6.99 Million USD -431.694%
Fresh Tracks Therapeutics, Inc. 1.65 Million USD -2145.894%
Molecular Templates, Inc. 31.17 Million USD -19.316%
Acrivon Therapeutics, Inc. Common Stock 17.07 Million USD -117.879%
Travere Therapeutics, Inc. 588.1 Million USD 93.676%
Monte Rosa Therapeutics, Inc. 124.5 Million USD 70.128%
Spruce Biosciences, Inc. 27.43 Million USD -35.554%
Celldex Therapeutics, Inc. 36.45 Million USD -2.019%
Cogent Biosciences, Inc. 55.63 Million USD 33.15%
MacroGenics, Inc. 154.2 Million USD 75.882%
RenovoRx, Inc. 4.46 Million USD -732.781%
Adicet Bio, Inc. 37.12 Million USD -0.194%
Prime Medicine, Inc. 60.78 Million USD 38.809%
Aditxt, Inc. 28.53 Million USD -30.354%
Adagene Inc. 45.16 Million USD 17.661%
Estrella Immunopharma, Inc. 180.7 Thousand USD -20482.067%
Quantum-Si incorporated 26.63 Million USD -39.657%
Maravai LifeSciences Holdings, Inc. 697.56 Million USD 94.668%
Acurx Pharmaceuticals, Inc. 3.04 Million USD -1122.441%
Voyager Therapeutics, Inc. 114.96 Million USD 67.648%
SciSparc Ltd. 1.59 Million USD -2231.787%
Vericel Corporation 127.7 Million USD 70.877%
Revelation Biosciences, Inc. 5.56 Million USD -568.333%
Minerva Neurosciences, Inc. 85.35 Million USD 56.428%
Generation Bio Co. 171.63 Million USD 78.33%
Astria Therapeutics, Inc. 11.55 Million USD -222.009%
Black Diamond Therapeutics, Inc. 41.83 Million USD 11.09%
Arcutis Biotherapeutics, Inc. 252.69 Million USD 85.282%
Invivyd, Inc. 51.71 Million USD 28.08%
Relay Therapeutics, Inc. 91.97 Million USD 59.564%
Quoin Pharmaceuticals, Ltd. 6.5 Million USD -471.723%
Spero Therapeutics, Inc. 75.49 Million USD 50.736%
Artelo Biosciences, Inc. 1.02 Million USD -3542.703%
2seventy bio, Inc. 310.12 Million USD 88.007%
ADMA Biologics, Inc. 193.97 Million USD 80.826%
Clene Inc. 38.95 Million USD 4.516%
Capricor Therapeutics, Inc. 36.13 Million USD -2.931%
Boundless Bio, Inc. Common Stock 256.97 Million USD 85.527%
GeoVax Labs, Inc. 3.51 Million USD -956.627%
Recursion Pharmaceuticals, Inc. 190.26 Million USD 80.452%
Citius Pharmaceuticals, Inc. 12.17 Million USD -205.362%
Contineum Therapeutics, Inc. Class A Common Stock 198.32 Million USD 81.247%
Relmada Therapeutics, Inc. 12.19 Million USD -204.982%
Finch Therapeutics Group, Inc. 48.11 Million USD 22.695%
ALX Oncology Holdings Inc. 52.84 Million USD 29.615%
Vir Biotechnology, Inc. 369.85 Million USD 89.944%
Evaxion Biotech A/S 17.61 Million USD -111.109%
Ocular Therapeutix, Inc. 160.92 Million USD 76.889%
Verve Therapeutics, Inc. 153.18 Million USD 75.721%
Trevena, Inc. 48.26 Million USD 22.937%
Surrozen, Inc. 8.14 Million USD -356.624%
Tyra Biosciences, Inc. 21.59 Million USD -72.225%
Cingulate Inc. 10.36 Million USD -258.966%
Galmed Pharmaceuticals Ltd. 2.75 Million USD -1252.436%
Unity Biotechnology, Inc. 37.29 Million USD 0.268%
Tenax Therapeutics, Inc. 3.58 Million USD -936.994%
Terns Pharmaceuticals, Inc. 13.15 Million USD -182.829%
ACADIA Pharmaceuticals Inc. 317.2 Million USD 88.275%
Connect Biopharma Holdings Limited 24.84 Million USD -49.672%
Clearmind Medicine Inc. 3.61 Million USD -930.247%
Kronos Bio, Inc. 54.2 Million USD 31.381%
Bolt Biotherapeutics, Inc. 47.04 Million USD 20.94%
CERo Therapeutics Holdings, Inc. 22.75 Million USD -63.411%
Viking Therapeutics, Inc. 20.07 Million USD -85.302%
Statera Biopharma, Inc. 22.67 Million USD -64.012%
ImmunityBio, Inc. 1.09 Billion USD 96.589%
Korro Bio, Inc. 51.75 Million USD 28.134%
Kineta, Inc. 7.22 Million USD -414.982%
BioVie Inc. 9.7 Million USD -283.339%
Codexis, Inc. 49.94 Million USD 25.536%
Celularity Inc. 102.92 Million USD 63.866%
Crinetics Pharmaceuticals, Inc. 96.24 Million USD 61.358%
Celcuity Inc. 51.45 Million USD 27.712%
Virax Biolabs Group Limited 345.19 Thousand USD -10674.231%
Cibus, Inc. 206.11 Million USD 81.956%
Eledon Pharmaceuticals, Inc. 42.47 Million USD 12.438%
eFFECTOR Therapeutics, Inc. 26.33 Million USD -41.205%
IN8bio, Inc. 8.77 Million USD -323.985%
Kodiak Sciences Inc. 213.59 Million USD 82.587%
Annexon, Inc. 47.11 Million USD 21.066%
Adverum Biotechnologies, Inc. 89.54 Million USD 58.464%
Assembly Biosciences, Inc. 96.37 Million USD 61.408%
Avalo Therapeutics, Inc. 13.68 Million USD -171.693%
Ionis Pharmaceuticals, Inc. 2.6 Billion USD 98.571%
Eyenovia, Inc. 19.78 Million USD -88.026%
Puma Biotechnology, Inc. 177.08 Million USD 78.998%
Conduit Pharmaceuticals Inc. 7.68 Million USD -384.208%
Xilio Therapeutics, Inc. 24.09 Million USD -54.33%
Arcellx, Inc. 339.75 Million USD 89.053%
Cardiff Oncology, Inc. 11.89 Million USD -212.59%
Enanta Pharmaceuticals, Inc. 245.54 Million USD 84.853%
Regulus Therapeutics Inc. 9.56 Million USD -288.916%
Moolec Science SA 13.94 Million USD -166.698%
Acumen Pharmaceuticals, Inc. 43.15 Million USD 13.812%
Geron Corporation 146.12 Million USD 74.548%
LAVA Therapeutics N.V. 50.53 Million USD 26.399%
Royalty Pharma plc 6.29 Billion USD 99.409%
Atea Pharmaceuticals, Inc. 39.77 Million USD 6.496%
Greenwich LifeSciences, Inc. 294.4 Thousand USD -12532.895%
TFF Pharmaceuticals, Inc. 2.46 Million USD -1411.697%
Mersana Therapeutics, Inc. 189.15 Million USD 80.338%
Humacyte, Inc. 114.67 Million USD 67.568%
Structure Therapeutics Inc. 29.05 Million USD -28.023%
89bio, Inc. 59.96 Million USD 37.975%
PMV Pharmaceuticals, Inc. 26.46 Million USD -40.543%
Avenue Therapeutics, Inc. 1.19 Million USD -3009.699%
Genelux Corporation 8.42 Million USD -341.71%
Trevi Therapeutics, Inc. 6.85 Million USD -442.474%
Lexicon Pharmaceuticals, Inc. 136.31 Million USD 72.717%
Notable Labs, Ltd. 4.42 Million USD -740.117%
Liquidia Corporation 73.13 Million USD 49.148%
Mustang Bio, Inc. 17.61 Million USD -111.09%
Immunovant, Inc. 48.95 Million USD 24.028%
Quantum-Si incorporated 26.63 Million USD -39.657%
Arbutus Biopharma Corporation 38.38 Million USD 3.103%
DiaMedica Therapeutics Inc. 3.1 Million USD -1098.582%
Vera Therapeutics, Inc. 73.86 Million USD 49.646%
Acasti Pharma Inc. 11.55 Million USD -221.814%
MiNK Therapeutics, Inc. 22.6 Million USD -64.51%
Pasithea Therapeutics Corp. 2.71 Million USD -1268.155%
Xenon Pharmaceuticals Inc. 36.87 Million USD -0.854%
Elevai Labs, Inc. Common Stock 1.36 Million USD -2629.003%
NeuroBo Pharmaceuticals, Inc. 6.09 Million USD -510.105%
Tempest Therapeutics, Inc. 24.83 Million USD -49.756%
Soleno Therapeutics, Inc. 23.18 Million USD -60.421%
PepGen Inc. 34.63 Million USD -7.395%
Moleculin Biotech, Inc. 12.14 Million USD -206.258%
United Therapeutics Corporation 1.18 Billion USD 96.854%
Nuvectis Pharma, Inc. 6.98 Million USD -432.532%
Solid Biosciences Inc. 38.45 Million USD 3.292%
BriaCell Therapeutics Corp. 8.55 Million USD -334.629%
Immuneering Corporation 12 Million USD -209.718%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -11749.945%
Silo Pharma, Inc. 1.56 Million USD -2270.019%
Belite Bio, Inc 4.21 Million USD -783.211%
XOMA Corporation 145.58 Million USD 74.453%
ARS Pharmaceuticals, Inc. 2.42 Million USD -1431.796%
Bionomics Limited 10.15 Million USD -266.109%
Apogee Therapeutics, Inc. 21.49 Million USD -73.058%
Alpha Tau Medical Ltd. 22.91 Million USD -62.318%
uniQure N.V. 624.01 Million USD 94.04%
Cassava Sciences, Inc. 14.19 Million USD -162.008%
Estrella Immunopharma, Inc. 180.7 Thousand USD -20482.067%
Poseida Therapeutics, Inc. 170.18 Million USD 78.146%
Forte Biosciences, Inc. 3.66 Million USD -914.512%
Anebulo Pharmaceuticals, Inc. 260.58 Thousand USD -14172.612%
Enlivex Therapeutics Ltd. 6.74 Million USD -451.238%
Conduit Pharmaceuticals Inc. 7.68 Million USD -384.208%
SeaStar Medical Holding Corporation 17.38 Million USD -113.956%
FibroBiologics, Inc. Common Stock 10.56 Million USD -251.93%
Altimmune, Inc. 16.54 Million USD -124.847%
Amicus Therapeutics, Inc. 617.7 Million USD 93.979%
Alpha Tau Medical Ltd. 22.91 Million USD -62.318%
Compugen Ltd. 55.77 Million USD 33.318%
Peak Bio, Inc. 20.75 Million USD -79.21%
Zevra Therapeutics, Inc. 110.46 Million USD 66.331%
Benitec Biopharma Inc. 4.96 Million USD -649.536%
Spyre Therapeutics, Inc. 157.84 Million USD 76.437%
NKGen Biotech, Inc. Common Stock 75.17 Million USD 50.525%
Zura Bio Limited 21.29 Million USD -74.676%
PolyPid Ltd. 17.46 Million USD -112.915%
Aileron Therapeutics, Inc. 112.39 Million USD 66.911%
NKGen Biotech, Inc. Warrants 75.17 Million USD 50.525%
Instil Bio, Inc. 99.8 Million USD 62.734%
argenx SE 444.95 Million USD 91.641%
Immunome, Inc. 28.65 Million USD -29.779%
Compass Therapeutics, Inc. 8.33 Million USD -346.108%
Verona Pharma plc 58.84 Million USD 36.792%
enGene Holdings Inc. Warrants 14.47 Million USD -156.975%
Shattuck Labs, Inc. 14.85 Million USD -150.299%
CervoMed Inc. 2.59 Million USD -1332.805%
LENZ Therapeutics, Inc. 4.87 Million USD -663.069%
Plus Therapeutics, Inc. 12.73 Million USD -192.023%
Dianthus Therapeutics, Inc. 10.53 Million USD -253.033%
Moolec Science SA 13.94 Million USD -166.698%
Enveric Biosciences, Inc. 2.34 Million USD -1487.025%
Inovio Pharmaceuticals, Inc. 55.59 Million USD 33.102%
AnaptysBio, Inc. 364.28 Million USD 89.79%
Design Therapeutics, Inc. 11.95 Million USD -211.074%
Leap Therapeutics, Inc. 12.68 Million USD -193.22%
NeurAxis, Inc. 1.91 Million USD -1844.437%
Seelos Therapeutics, Inc. 38.92 Million USD 4.46%
Lumos Pharma, Inc. 13.33 Million USD -178.947%
Achilles Therapeutics plc 19.08 Million USD -94.855%
enGene Holdings Inc. Common Stock 14.47 Million USD -156.975%
180 Life Sciences Corp. 5.38 Million USD -590.376%
Opiant Pharmaceuticals, Inc. 23.58 Million USD -57.673%
CERo Therapeutics Holdings, Inc. 22.75 Million USD -63.411%
Nutriband Inc. 1.07 Million USD -3347.154%
ORIC Pharmaceuticals, Inc. 30.59 Million USD -21.55%
CG Oncology, Inc. Common stock 14.51 Million USD -156.302%
Fractyl Health, Inc. Common Stock 401.27 Million USD 90.732%
Rani Therapeutics Holdings, Inc. 32.47 Million USD -14.532%
MoonLake Immunotherapeutics 13.04 Million USD -185.016%
Palisade Bio, Inc. 2.73 Million USD -1257.868%
Tourmaline Bio, Inc. 5.25 Million USD -608.014%
Beam Therapeutics Inc. 478.38 Million USD 92.226%
Neurogene Inc. 36.54 Million USD -1.759%
Mirum Pharmaceuticals, Inc. 397.95 Million USD 90.654%
AEON Biopharma, Inc. 159.88 Million USD 76.739%
CARGO Therapeutics, Inc. Common Stock 47.65 Million USD 21.948%
Sesen Bio, Inc. 30.98 Million USD -20.036%
Enliven Therapeutics, Inc. 25.96 Million USD -43.261%
Kiora Pharmaceuticals, Inc. 7.6 Million USD -389.226%
Iovance Biotherapeutics, Inc. 195.73 Million USD 80.999%
Taysha Gene Therapies, Inc. 192.05 Million USD 80.635%
Athira Pharma, Inc. 30.05 Million USD -23.738%
Vaccinex, Inc. 5.94 Million USD -525.917%
HCW Biologics Inc. 15.05 Million USD -147.091%
XOMA Corporation 145.58 Million USD 74.453%
Nektar Therapeutics 267.04 Million USD 86.073%
Arvinas, Inc. 644.6 Million USD 94.23%
Tevogen Bio Holdings Inc. 17.73 Million USD -109.732%
Merus N.V. 102.15 Million USD 63.591%
Omega Therapeutics, Inc. 146.35 Million USD 74.587%
Quince Therapeutics, Inc. 95.12 Million USD 60.9%
Rezolute, Inc. 11.73 Million USD -216.959%
Clene Inc. 38.95 Million USD 4.516%
Indaptus Therapeutics, Inc. 2.84 Million USD -1206.183%
BeyondSpring Inc. 48.26 Million USD 22.948%
Synlogic, Inc. 32.89 Million USD -13.063%
Allarity Therapeutics, Inc. 14.61 Million USD -154.513%
Phio Pharmaceuticals Corp. 1.63 Million USD -2176.132%
Peak Bio, Inc. 20.75 Million USD -79.21%
Werewolf Therapeutics, Inc. 63.45 Million USD 41.392%
Krystal Biotech, Inc. 39.71 Million USD 6.35%
Karyopharm Therapeutics Inc. 376.64 Million USD 90.125%
SpringWorks Therapeutics, Inc. 99.56 Million USD 62.647%
Lipella Pharmaceuticals Inc. 432.72 Thousand USD -8494.815%
MannKind Corporation 721.36 Million USD 94.844%
Ikena Oncology, Inc. 22.33 Million USD -66.519%
Cyclerion Therapeutics, Inc. 2.08 Million USD -1682.934%
Gyre Therapeutics, Inc. 102.59 Million USD 63.747%
Gossamer Bio, Inc. 249.14 Million USD 85.072%
CohBar, Inc. 1.03 Million USD -3498.165%
Cognition Therapeutics, Inc. 10.68 Million USD -247.946%
NRx Pharmaceuticals, Inc. 19.04 Million USD -95.254%
Legend Biotech Corporation 589.93 Million USD 93.696%
Mural Oncology plc 37.92 Million USD 1.941%
Biora Therapeutics, Inc. 132.63 Million USD 71.959%
PaxMedica, Inc. Common Stock 2.29 Million USD -1520.332%
Disc Medicine, Inc. 22.87 Million USD -62.588%
Champions Oncology, Inc. 28.03 Million USD -32.663%
REGENXBIO Inc. 262.22 Million USD 85.817%
Ensysce Biosciences, Inc. 3.35 Million USD -1007.118%
Anavex Life Sciences Corp. 12.53 Million USD -196.729%
Cellectar Biosciences, Inc. 13.43 Million USD -176.899%
Edgewise Therapeutics, Inc. 21.2 Million USD -75.393%
Vaxart, Inc. 34.02 Million USD -9.308%
PharmaCyte Biotech, Inc. 20.38 Million USD -82.41%
Aldeyra Therapeutics, Inc. 28.53 Million USD -30.352%
Cellectis S.A. 249.57 Million USD 85.098%
Longeveron Inc. 5.33 Million USD -596.871%
Repare Therapeutics Inc. 41.81 Million USD 11.064%
Sarepta Therapeutics, Inc. 2.4 Billion USD 98.454%
Inozyme Pharma, Inc. 60.36 Million USD 38.391%
Revolution Medicines, Inc. 262.39 Million USD 85.826%
Nymox Pharmaceutical Corporation 2.1 Million USD -1665.164%
Third Harmonic Bio, Inc. 8.62 Million USD -331.162%
ArriVent BioPharma, Inc. Common Stock 11.8 Million USD -215.16%
AN2 Therapeutics, Inc. 14.04 Million USD -164.844%
Anixa Biosciences, Inc. 2.15 Million USD -1629.056%
Vertex Pharmaceuticals Incorporated 5.14 Billion USD 99.278%
Denali Therapeutics Inc. 122.96 Million USD 69.754%
Revelation Biosciences, Inc. 5.56 Million USD -568.333%
Veru Inc. 32.81 Million USD -13.346%
Corvus Pharmaceuticals, Inc. 6.86 Million USD -441.447%
Cingulate Inc. 10.36 Million USD -258.966%
Passage Bio, Inc. 39.26 Million USD 5.272%
Context Therapeutics Inc. 4.19 Million USD -787.274%
Exicure, Inc. 8.54 Million USD -335.045%
Day One Biopharmaceuticals, Inc. 29.5 Million USD -26.04%
Oramed Pharmaceuticals Inc. 10.48 Million USD -254.682%
Scinai Immunotherapeutics Ltd. 22.04 Million USD -68.74%
Rhythm Pharmaceuticals, Inc. 162.98 Million USD 77.181%
Nuvalent, Inc. 31.82 Million USD -16.871%
ABVC BioPharma, Inc. 6.36 Million USD -484.63%
Carisma Therapeutics, Inc. 63.02 Million USD 40.986%
Unicycive Therapeutics, Inc. 18 Million USD -106.622%
OmniAb, Inc. 87.4 Million USD 57.446%
Anew Medical, Inc. 8.24 Million USD -351.261%
Fennec Pharmaceuticals Inc. 38.28 Million USD 2.865%
Lipocine Inc. 2.63 Million USD -1313.269%
Lexeo Therapeutics, Inc. Common Stock 26.27 Million USD -41.565%
Nautilus Biotechnology, Inc. 40.21 Million USD 7.51%
SAB Biotherapeutics, Inc. 26.64 Million USD -39.6%
G1 Therapeutics, Inc. 86.15 Million USD 56.831%
Bellerophon Therapeutics, Inc. 5.4 Million USD -588.613%
Sage Therapeutics, Inc. 82.74 Million USD 55.053%
Ocugen, Inc. 23.98 Million USD -55.077%
Mind Medicine (MindMed) Inc. 46.4 Million USD 19.857%
Q32 Bio Inc. 233.12 Million USD 84.047%
Brainstorm Cell Therapeutics Inc. 9.06 Million USD -310.236%
Alumis Inc. Common Stock 53.5 Million USD 30.485%
Equillium, Inc. 27.95 Million USD -33.033%
Kyverna Therapeutics, Inc. 206.59 Million USD 81.997%
Coya Therapeutics, Inc. 5.62 Million USD -560.995%
CNS Pharmaceuticals, Inc. 6.13 Million USD -506.427%
Galera Therapeutics, Inc. 157.32 Million USD 76.36%
Evelo Biosciences, Inc. 69.43 Million USD 46.435%
Comera Life Sciences Holdings, Inc. 9.97 Million USD -272.882%
Dominari Holdings Inc. 4.63 Million USD -702.416%
Edesa Biotech, Inc. 1.84 Million USD -1919.508%
vTv Therapeutics Inc. 29.56 Million USD -25.789%
Bio-Techne Corporation 744.34 Million USD 95.003%
Agios Pharmaceuticals, Inc. 126.09 Million USD 70.506%
Harmony Biosciences Holdings, Inc. 344.45 Million USD 89.203%
Prelude Therapeutics Incorporated 40.57 Million USD 8.338%
Candel Therapeutics, Inc. 28.95 Million USD -28.439%
iTeos Therapeutics, Inc. 92.36 Million USD 59.731%
Nkarta, Inc. 105.6 Million USD 64.78%
BioCardia, Inc. 4.59 Million USD -710.283%
Iterum Therapeutics plc 32.66 Million USD -13.869%